Issue 84, 2022

GSH-Triggered NO releasing nanoplatform based on a covalent organic framework for “1 + 1 > 2” synergistic cancer therapy

Abstract

A porphyrin containing covalent organic framework (COF) was developed as the glutathione responsive nitric oxide (NO) donor delivery nanoplatform for “1 + 1 > 2” synergistic cancer therapy of NO mediated therapy and photodynamic therapy.

Graphical abstract: GSH-Triggered NO releasing nanoplatform based on a covalent organic framework for “1 + 1 > 2” synergistic cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
06 Aug 2022
Accepted
26 Sep 2022
First published
27 Sep 2022

Chem. Commun., 2022,58, 11803-11806

GSH-Triggered NO releasing nanoplatform based on a covalent organic framework for “1 + 1 > 2” synergistic cancer therapy

X. Wan, T. Zheng, D. Wang, W. Pan, Y. Gao, N. Li and B. Tang, Chem. Commun., 2022, 58, 11803 DOI: 10.1039/D2CC04393A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements